The Cytotoxicity of Bupivacaine, Ropivacaine, and Mepivacaine on Human Chondrocytes and Cartilage
- 1 August 2013
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Anesthesia & Analgesia
- Vol. 117 (2), 514-522
- https://doi.org/10.1213/ane.0b013e31829481ed
Abstract
Intraarticular injections of local anesthetics are frequently used as part of multimodal pain regimens. However, recent data suggest that local anesthetics affect chondrocyte viability. In this study, we assessed the chondrotoxic effects of mepivacaine, ropivacaine, and bupivacaine. We hypothesized that specific cytotoxic potencies directly correlate with analgesic potencies, and that cytotoxic effects in intact cartilage are different than in osteoarthritic tissue. Human articular chondrocytes were exposed to equal and equipotent concentrations of bupivacaine, ropivacaine, and mepivacaine for 1 hour. Cell viability, apoptosis, and necrosis were determined at predefined time points using flow cytometry, live-dead staining, and caspase detection. Intact and osteoarthritic human cartilage explants were treated with equipotent concentrations of named drugs to determine cell viability applying fluorescence microscopy. Chondrotoxic effects increased from ropivacaine to mepivacaine to bupivacaine in a time-dependent and concentration-dependent manner. Compared with control, bupivacaine 0.5% decreased chondrocyte viability to 78% ± 9% (P = 0.0183) 1 hour and 16% ± 10% (P < 0.0001) 24 hours later, as determined by live-dead staining in monolayer cultures. Viability rates were reduced to 80% ± 7% (P = 0.0475) 1 hour and 80% ± 10% (P = 0.0095) 24 hours after treatment with ropivacaine 0.75%. After exposure to mepivacaine 2%, viable cells were scored 36% ± 6% (P < 0.0001) after 1 hour and 30% ± 11% (P < 0.0001) after 24 hours. Ropivacaine treatment was less chondrotoxic than bupivacaine (P = 0.0006) and mepivacaine exposure (P = 0.0059). Exposure to concentrations up to 0.25% of bupivacaine, 0.5% of ropivacaine, and 0.5% of mepivacaine did not reveal significant chondrotoxicity in flow cytometry. However, chondrotoxicity did not correlate with potency of local anesthetics. Immediate cell death was mainly due to necrosis followed by apoptosis. Cellular death rates were clearly higher in osteoarthritic compared with intact cartilage after bupivacaine, mepivacaine, and ropivacaine treatment in a decreasing order. Bupivacaine, ropivacaine, and mepivacaine are chondrotoxic in a time-dependent, concentration-dependent, and drug-dependent manner. Chondrotoxic and analgesic potencies do not directly correlate. Cellular death rates were higher in osteoarthritic compared with intact cartilage after local anesthetic treatment.Keywords
This publication has 29 references indexed in Scilit:
- Bupivacaine and Triamcinolone May Be Toxic To Human Chondrocytes: A Pilot StudyClinical Orthopaedics and Related Research, 2011
- Measurement of diffusion in articular cartilage using fluorescence correlation spectroscopyBMC Biotechnology, 2011
- Comparison of the cytotoxic effects of bupivacaine, lidocaine, and mepivacaine in equine articular chondrocytesVeterinary Anaesthesia and Analgesia, 2011
- Oxidative stress induces senescence in chondrocytesJournal of Orthopaedic Research, 2011
- Increased Chondrocyte Death after Steroid and Local Anesthetic CombinationClinical Orthopaedics and Related Research, 2010
- A Randomized, Prospective, Double-Blind Study to Investigate the Effectiveness of Adding DepoMedrol to a Local Anesthetic Injection in Postmeniscectomy Patients With Osteoarthritis of the KneeThe American Journal of Sports Medicine, 2009
- Current status and clinical relevance of studies of minimum local-anaesthetic concentration (MLAC)Current Opinion in Anaesthesiology, 2005
- The Acute Myotoxic Effects of Bupivacaine and Ropivacaine After Continuous Peripheral Nerve BlockadesAnesthesia & Analgesia, 2003
- An in situ calibration of an ultrasound transducer:: a potential application for an ultrasonic indentation test of articular cartilageJournal of Biomechanics, 2001
- Monitoring serum bupivacaïne levels during arthroscopyEuropean Journal of Clinical Pharmacology, 1985